CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated by Ana

StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright boosted their target price on shares of CASI Pharmaceuticals from $10.00 to $12.00 and gave the stock a buy […]

Related Keywords

United States , , Susquehanna International Group , Renaissance Technologies , Citigroup Inc , Pharmaceuticals Price Performance , Pharmaceuticals Daily , Pharmaceuticals Inc , Virtu Financial , Free Report , Get Free Report , International Group , Casi Pharmaceuticals , Nasdaq Casi , Casi , Medical , Initiated Coverage , Stocknews Com ,